Volume No. :   8

Issue No. :  1

Year :  2018

ISSN Print :  2231-5705

ISSN Online :  2231-5713


Registration

Allready Registrered
Click to Login

Prescription Analysis of Antiepileptic Drugs in a Tertiary Care Hospital



Address:   T. Tamilselvan2*, Arokia Rani C.1, Ashna Raj1, Leena Priya M.1, Nissy Varghese1, Sojan P. Paul2
1Pharm.D Interns, Department of Pharmacy Practice, Swamy Vivekanandha College of Pharmacy, Elayampalayam - 637205,
2Department of Pharmacy Practice, Swamy Vivekanandha College of Pharmacy, Elayampalayam - 637205,
*Corresponding Author
DOI No: 10.5958/2231-5713.2018.00007.7

ABSTRACT:
The objective of the study was to analyze the prescription pattern and drug related problems of antiepileptic drugs. The prospective descriptive study was carried out for a period of 6 months in a tertiary care hospital. The prescriptions were analyzed to identify the polypharmacy, adverse drug reactions and medication error. The patients were included in the study was with all type of epilepsy of both male and female patients with any age group of in and out patients. The identified medication error was categorized with the help of NCC MERP category. Causality assessment of adverse reaction was performed by the Naranjo algorithm. Analyzed the obtained prescription and identified the Polypharmacy in geriatric patients. Total 50 patients with 406 drugs, of these 6 Polypharmacy (12%), 7 medication error (16%) and 6 serious ADR were identified. The current study observed that the prescription contains drug-related problems were assessed to a greater extent and are comparable with the existing literature. Continued relationship with clinical pharmacist should be encouraged for better treatment option thereby improving the patient's quality of life effectively.
KEYWORDS:
Prescription, Epilepsy, Polypharmacy, Medication Error, Adverse Drug Reaction.
Cite:
T. Tamilselvan, Arokia Rani C., Ashna Raj, Leena Priya M., Nissy Varghese, Sojan P. Paul. Prescription Analysis of Antiepileptic Drugs in a Tertiary Care Hospital. Asian J. Pharm. Tech. 2018; 8 (1):43-46 .
[View HTML]     



Visitor's No. :   80500